Progyny, Inc. is an American benefits-management company that administers employer-sponsored fertility, family-building and women's-health benefits. The company began offering fertility benefits in 2016. It completed an initial public offering on the Nasdaq in 2019. In 2024, it was described as a pioneer in the field and the only publicly traded fertility-benefits company in the United States.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| PGNY | Progyny, Inc. | 2026-07-30 14:59:49 | 31.5 | 0.14 | 0.45 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGNY | 0001551306 | Progyny, Inc. | US74340E1038 | — | 272220139 | Nasdaq | 8090 | Services-Misc Health & Allied Services, NEC | 1231 | DE | 1359 BROADWAY | NEW YORK | NY | 10018 | UNITED STATES | US | 212-888-3124 | 1359 BROADWAY, NEW YORK, NY, 10018 | 1359 BROADWAY, NEW YORK, NY, 10018 | Auxogyn, Inc. | Health care | 2008-04-03 | Peter Anevski | 856 | https://progyny.com | 1,900,000,000 | 99,465,999 | 78,332,370 | Progyny, Inc. is an American benefits-management company that administers employer-sponsored fertility, family-building and women's-health benefits. The company began offering fertility benefits in 2016. It completed an initial public offering on the Nasdaq in 2019. In 2024, it was described as a pioneer in the field and the only publicly traded fertility-benefits company in the United States. | 2026-07-30 17:05:17 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 1,900,000,000 | -700,000,000 | -26.9231 | 81,902,232 | -3,511,051 | -4.1107 |
| 2024 | 2,600,000,000 | -700,000,000 | -21.2121 | 85,413,283 | -11,086,119 | -11.4883 |
| 2023 | 3,300,000,000 | 1,000,000,000 | 43.4783 | 96,499,402 | 3,121,159 | 3.3425 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Allison Swartz | EVP, General Counsel, Secretary | 2025 | 409,500 | 0 | 624,976 | 225,450 | 10,225 | 1,645,151 |
| Melissa Cummings | Chief Operating Officer | 2025 | 429,546 | 0 | 1,149,993 | 386,550 | 39,084 | 2,695,161 |
| Peter Anevski | Chief Executive Officer | 2025 | 870,000 | 0 | 3,499,980 | 736,890 | 13,747 | 7,220,612 |
| Mark Livingston | Chief Financial Officer | 2025 | 533,000 | 0 | 999,988 | 330,567 | 16,819 | 2,480,374 |
| Geoffrey Clapp | Chief Product Officer | 2025 | 336,458 | 0 | 749,979 | 226,525 | 9,666 | 1,772,628 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 856 |
| 2024 | 680 |
| 2023 | 566 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 1,288,661,000 | 1,167,221,000 | 1,088,598,000 |
| Cost Of Revenue | 984,177,000 | 913,858,000 | 849,799,000 |
| Gross Profit | 304,484,000 | 253,363,000 | 238,799,000 |
| Research And Development Expenses | 9,500,000 | — | — |
| General And Administrative Expenses | 147,094,000 | 121,960,000 | 117,127,000 |
| Operating Expenses | 219,207,000 | 185,908,000 | 176,615,000 |
| Operating Income | 85,277,000 | 67,455,000 | 62,184,000 |
| Net Income | 58,520,000 | 54,336,000 | 62,037,000 |
| Earnings Per Share Basic | 0.68 | 0.59 | 0.65 |
| Earnings Per Share Diluted | 0.65 | 0.57 | 0.62 |
| Weighted Average Shares Outstanding Basic | 85,651,721 | 91,481,995 | 95,021,175 |
| Weighted Average Shares Outstanding Diluted | 89,861,843 | 95,448,357 | 100,672,399 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 112,238,000 | 162,314,000 | 97,296,000 |
| Marketable Securities Current | 197,858,000 | 65,640,000 | 273,791,000 |
| Accounts Receivable | 220,287,000 | 235,324,000 | 241,869,000 |
| Inventories | — | — | — |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 21,392,000 | 9,443,000 | 27,451,000 |
| Total Assets Current | 551,775,000 | 472,721,000 | 640,407,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 29,927,000 | 12,383,000 | 10,213,000 |
| Other Assets Non Current | 16,536,000 | 2,977,000 | 3,395,000 |
| Total Assets Non Current | 190,660,000 | 134,381,000 | 116,213,000 |
| Total Assets | 742,435,000 | 607,102,000 | 756,620,000 |
| Accounts Payable | 124,071,000 | 95,097,000 | 125,426,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | — | — | — |
| Other Liabilities Current | 1,914,000 | 5,299,000 | 1,183,000 |
| Total Liabilities Current | 202,391,000 | 168,627,000 | 185,950,000 |
| Long Term Debt | — | — | — |
| Other Liabilities Non Current | — | — | — |
| Total Liabilities Non Current | 24,000,000 | 16,413,000 | 17,241,000 |
| Total Liabilities | 226,391,000 | 185,040,000 | 203,191,000 |
| Common Stock | 9,000 | 9,000 | 9,000 |
| Retained Earnings | 202,827,000 | 144,307,000 | 89,971,000 |
| Accumulated Other Comprehensive Income | 498,000 | 39,000 | 2,819,000 |
| Total Shareholders Equity | 516,044,000 | 422,062,000 | 553,429,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 4,948,000 | 3,175,000 | 2,281,000 |
| Share Based Compensation Expense | 131,867,000 | 128,130,000 | 122,611,000 |
| Other Non Cash Income Expense | -79,000 | -1,414,000 | — |
| Change In Accounts Receivable | 5,117,000 | 9,874,000 | 21,738,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | 11,947,000 | -18,018,000 | 22,930,000 |
| Change In Accounts Payable | 28,752,000 | -30,268,000 | 16,235,000 |
| Change In Other Liabilities | 417,000 | 9,924,000 | 10,361,000 |
| Cash From Operating Activities | 210,192,000 | 179,105,000 | 188,814,000 |
| Purchases Of Marketable Securities | 354,964,000 | 170,339,000 | 429,694,000 |
| Sales Of Marketable Securities | 223,701,000 | 376,840,000 | 232,813,000 |
| Acquisition Of Property Plant And Equipment | 18,410,000 | 5,405,000 | 3,644,000 |
| Acquisition Of Business | 9,340,000 | 5,304,000 | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -159,013,000 | 195,792,000 | -200,525,000 |
| Tax Withholding For Share Based Compensation | 15,848,000 | 12,001,000 | 17,200,000 |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 84,186,000 | 302,880,000 | — |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -99,362,000 | -309,880,000 | -11,072,000 |
| Change In Cash | -48,121,000 | 65,018,000 | -22,782,000 |
| Cash At End Of Period | 112,238,000 | 162,314,000 | 97,296,000 |
| Income Taxes Paid | 55,490,000 | 40,449,000 | 6,181,000 |
| Interest Paid | — | — | — |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 0.68 | 0.59 | 0.65 |
| Price To Earnings Ratio | 37.7647 | 29.2373 | 57.2 |
| Earnings Growth Rate | 15.2542 | -9.2308 | 96.9697 |
| Price Earnings To Growth Ratio | 2.4757 | -3.1674 | 0.5899 |
| Book Value Per Share | 6.0249 | 4.6136 | 5.8243 |
| Price To Book Ratio | 4.2623 | 3.7389 | 6.3836 |
| Ebitda | 118,958,000 | 97,960,000 | 73,803,000 |
| Enterprise Value | — | — | — |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | — | — | — |
| Capital Expenditures | 22,492,000 | 5,345,000 | 4,123,000 |
| Free Cash Flow | 187,700,000 | 173,760,000 | 184,691,000 |
| Return On Equity | 0.1134 | 0.1287 | 0.1121 |
| One Year Beta | 0.5761 | 0.4332 | 1.1174 |
| Three Year Beta | 0.6714 | 1.2511 | 1.4358 |
| Five Year Beta | 1.1039 | 1.3325 | 1.4072 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Cummings Melissa B | Chief Operating Officer | 2026-07-14 | 1,193 | D | 72,178 |
| Cummings Melissa B | Chief Operating Officer | 2026-07-14 | 2,244 | D | 69,934 |
| Clapp Geoffrey | Chief Product Officer | 2026-06-17 | 819 | D | 59,828 |
| Livingston Mark S. | CHIEF FINANCIAL OFFICER | 2026-06-04 | 339 | D | 77,205 |
| Livingston Mark S. | CHIEF FINANCIAL OFFICER | 2026-06-04 | 1,918 | D | 75,287 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Josh Gottheimer | 2025-01-14 | NJ05 | Sale | 2024-12-06 | Joint | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| HAZLETT, BURT & WATSON, INC. | 2026-06-30 | 3,000 | 93 | 32.2581 |
| ASSETMARK, INC | 2026-06-30 | 663 | 23 | 28.8261 |
| Pictet Asset Management Holding SA | 2026-06-30 | 273,107 | 9,473 | 28.83 |
| Maryland State Retirement & Pension System | 2026-06-30 | 303,234 | 10,518 | 28.83 |
| STRS OHIO | 2026-06-30 | 1,046,529 | 36,300 | 28.83 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| SHELTON FUNDS | 2026-05-31 | K Shares | SMLKX | 2,230 | 56,998.8 | 0.1183 |
| SHELTON FUNDS | 2026-05-31 | Investor Shares | SMCIX | 2,230 | 56,998.8 | 0.1183 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 2026-05-31 | Invesco Russell 2000(R) Dynamic Multifactor ETF | OMFS | 93,245 | 2,383,342.2 | 0.8411 |
| AMERICAN CENTURY ETF TRUST | 2026-05-31 | Avantis U.S. Small Cap Equity ETF | AVSC | 113,078 | 2,890,273.68 | 0.1037 |
| AMERICAN CENTURY ETF TRUST | 2026-05-31 | Avantis U.S. Small Cap Value ETF | AVUV | 42,337 | 1,082,133.72 | 0.004 |